Multiple Sclerosis
Conference Coverage
Portable MRI has potential for MS
A blinded study showed good agreement with high-field MRI for some applications, but more development is needed.
Conference Coverage
A better MS measure?
A ‘digital carpet’ may provide more granular information about functional decline in patients with MS.
Conference Coverage
Cutting calories may benefit cognition in MS
For patients with MS, cognition can be positively influenced by healthy dietary habits.
Conference Coverage
High level of psychiatric morbidity in prodromal MS
The relative risk of psychiatric morbidity was up to 88% higher in patients with MS, compared with their counterparts without the disease.
Conference Coverage
MOGAD: Immunotherapy predicts fewer relapses
IVIG therapy appears to be the most effective for reducing relapses.
Conference Coverage
To prevent MS, should we target EBV?
Can a vaccine against EBV reduce MS incidence on a population level? Two experts debate.
Conference Coverage
Differential diagnosis in MS: What to watch for
‘Red flags’ suggest something other than MS.
Conference Coverage
CBT alone and with meds may decrease MS fatigue
“Clinicians should consider clinical characteristics and overall treatment goals when selecting fatigue interventions, to offer a more...
Expert Perspective
Anti-CD20 Monoclonal Antibodies for Treating Multiple Sclerosis
Literature Review
Biosimilar equal to natalizumab for relapsing remitting MS
Biosim-NTZ is the first biosimilar monoclonal antibody therapy to be developed for MS.